MarketInOut Stock Screener Log In | Sign Up
 

ALK-Abelló A/S

CPH • Healthcare • Biotechnology • Quote as of 10/23/2026 16:59
ALK-Abelló A/S stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeCPH
Market Capitalization51,121 mln
Float132 mln
Earnings Date11/17/2026

EPS

6.10
Stretched

P / E

39.87
Overvalued

1-Year Forecast

291.00
Attractive

Relative Strength

95 / 100
Top performer

Debt / Equity

0.06
Debt-free

Pre-Tax Margin

27%
Strong margin

Business Description

Founded in 1923 and based in Hørsholm, Denmark, ALK-Abelló is a medical company focused on helping people manage and treat allergies. Its core products include a range of immunotherapy treatments ? delivered as tablets, drops, or injections ? that target common allergies such as grass and tree pollen, house dust mites, ragweed, and peanuts, along with emergency medicines for severe allergic reactions like anaphylaxis. The company also offers diagnostic tools, a digital platform to help patients track and manage their condition, and is developing new biological treatments for food allergies. ALK-Abelló operates across Europe, North America, Asia, and other markets, working with partners such as Torii Pharmaceutical and Dr. Reddy's Laboratories to bring its products to patients worldwide.

Key Fundamentals

EPS6.10
P/E39.87
ROE21.21
RPS30.73
ROIC16.10
ROA12.74
Interest Cover456
EBITDA, mln2,095
EV / EBITDA23.46
Revenue, mln6,829
EV / Revenue7.20

Quote Details

Last 242.80
Change 2.2 (0.91%)
Open 241.20
Volume 143,658
Turnover 34,880,164
Average Volume 237,731

Financial Ratios

Pre-Tax Profit Margin27
Leverage Ratio1.40
Current Ratio3.46
Price / Book7.36
Price / Cash Flow23.69
Price / Free Cash Flow27.57
Debt / Equity0.06
Price / Sales7.48
PEG Ratio9.87

Financial Strength

1-Year Target Price291.00

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.77% 97 / 100   
1 Month 23.37% 99 / 100   
2 Months 2.97% 70 / 100   
6 Months 7.53% 57 / 100   
1 Year 13.79% 42 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog